Evidence map›Paper›PMID 29476659›Full record

ArticleMolecular microbiology2018

The evolutionary impact of intragenic FliA promoters in proteobacteria.

Devon M Fitzgerald, Carol Smith, Pascal Lapierre, Joseph T Wade

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Origin and adaptive evolutionary trajectory of the 3' UTR-derived sRNA UhpU in Enterobacteriaceae.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. σeLife · 2023
    Article
  5. Article
  6. Genome-wide mapping of thebioRxiv : the preprint server for biology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Devon M FitzgeraldDepartment of Biomedical Sciences, School of Public Health, University at Albany, Albany, New York, USA.ORCID 0000-0002-2480-7269
Carol SmithWadsworth Center, New York State Department of Health, Albany, New York, USA.
Pascal LapierreWadsworth Center, New York State Department of Health, Albany, New York, USA.
Joseph T WadeDepartment of Biomedical Sciences, School of Public Health, University at Albany, Albany, New York, USA.ORCID 0000-0002-9779-3160
New York State Department of Health · USUniversity at Albany, State University of New York · US

Funding

Pervasive transcription in bacterial genomesDP2OD007188 · OD · WADSWORTH CENTER · PI WADE, JOSEPH THOMAS · 2010 to 2010
$2.4M
Training in Biodefense and Emerging Infectious DiseaseT32AI055429 · NIAID · WADSWORTH CENTER · PI MCDONOUGH, KATHLEEN A · 2004 to 2014
$2.2M
Global mapping and analysis of a bacterial transcriptional regulatory networkR01GM114812 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GALAGAN, JAMES E · 2015 to 2018
$2.1M
NIAID NIH HHS T32 AI055429NIGMS NIH HHS R01 GM114812NIH HHS DP2 OD007188
6 · The paper itself

Abstract

In Escherichia coli, one sigma factor recognizes the majority of promoters, and six 'alternative' sigma factors recognize specific subsets of promoters. The alternative sigma factor FliA (σ

Indexed as

Evolution, MolecularBacterial Proteinsbeta-GalactosidaseBinding SitesChromosome MappingEscherichia coliPlasmidsPromoter Regions, GeneticRNASalmonella typhimuriumSequence Analysis, DNASequence Analysis, RNASigma FactorTranscription, GeneticBacterial Proteinsbeta-GalactosidaseFliA protein, BacteriaRNASigma Factor

Identifiers

PMID29476659
PMCPMC5943157
OpenAlexW2949344431

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.